--- title: "Vital Signs #34: Study: More Than 1,000 Seed-Funded Startups Are Destined To Be ‘Orphaned’ At The Series A Stage" description: There is a lot of buzz about an ongoing “Series A crunch” for tech startups, but it’s ideal to have real data to accompany all the anecdotal storie --- # Vital Signs #34: Study: More Than 1,000 Seed-Funded Startups Are Destined To Be ‘Orphaned’ At The Series A Stage Published by [ Scott Jordan ](https://www.sjordanassociates.com/blog/author/scott-jordan) on Fri, Dec 28, 2012 @ 12:31 PM There is a lot of buzz about an [ongoing “Series A crunch”](http://techcrunch.com/2011/11/09/crunchcrunch/) for tech startups, but it’s ideal to have real data to accompany all the anecdotal stories. So we were glad to see that today, venture capital analysis firm [CB Insights](http://www.cbinsights.com/) released a new [seed financing report](http://www.cbinsights.com/blog/trends/seed-investing-report) that digs into some real numbers about the situation. The good news? The level of Series A funding is actually holding steady, not declining, according to the research. The “crunch” is perceived because of the boom in seed funding, which has brought a greater quantity of startups to the table looking for Series A funding than there had ever been before. Essentially, it’s a supply and demand issue — the supply of Series A money has not fallen by any means, but the demand for it from seed-funded startups is just incredibly large right now. [http://techcrunch.com/2012/12/19/study-more-than-1000-seed-funded-startups-are-destined-to-be-orphaned-at-the-series-a-stage/?goback=.gde_3889651_member_198671140](http://techcrunch.com/2012/12/19/study-more-than-1000-seed-funded-startups-are-destined-to-be-orphaned-at-the-series-a-stage/?goback=.gde_3889651_member_198671140)   [Back to Blog](https://www.sjordanassociates.com/blog) - [Tweet](https://twitter.com/share) ## Related Articles ## [#12: Article Confirms Challenges Facing Early-Stage Biotech Companies ](https://www.sjordanassociates.com/blog/bid/163243/12-Article-Confirms-Challenges-Facing-Early-Stage-Biotech-Companies) FierceBiotech, January 23, 2012: VCs pump more cash into late-stage efforts as startup rounds... [Read More ](https://www.sjordanassociates.com/blog/bid/163243/12-Article-Confirms-Challenges-Facing-Early-Stage-Biotech-Companies) ## [Vital Signs #142: Did The SEC Just Kill Early Stage Venture Capital?](https://www.sjordanassociates.com/blog/bid/404629/Vital-Signs-142-Did-The-SEC-Just-Kill-Early-Stage-Venture-Capital) [Read More ](https://www.sjordanassociates.com/blog/bid/404629/Vital-Signs-142-Did-The-SEC-Just-Kill-Early-Stage-Venture-Capital) ## [Startups Vie to Build an Uber for Health Care](https://www.sjordanassociates.com/blog/bid/406759/Startups-Vie-to-Build-an-Uber-for-Health-Care) Melinda Beck, August 11, 2015 [Read More ](https://www.sjordanassociates.com/blog/bid/406759/Startups-Vie-to-Build-an-Uber-for-Health-Care)